Replies to post #764819 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Antihama, you are correct that licensed=approval but here is the problem:

Supposing that a few days or a month ago, the CHM has decided that the MAA can
move towards approval. The MHRA can than respond to the parliamentary
questions it had received in the following ways.
1. The MAA has not as yet received our approval.
2. The MAA has not as yet received our official approval.
3. The company (NWBO) has not yet been licensed for the commercial
sale of the vaccine (which is a prerequisite for reimbursement).

Using the No. 1 answer would be misleading because while the MAA has not
been officially approved, the CHM's nod to approve, has moved the MAA toward
official approval.

Using No. 2 as an answer would hint that while the MAA has not yet received
official approval, it has already received tentative approval. That is something the
MHRA would never do.

Employing No. 3 as an answer was the best path because "not yet licensed"
does not reveal whether or not DCVax-L already received an unofficial MAA approval.

I am not saying that the MAA has already received the unofficial approval but the
MHRA's answer to the parliamentary question leaves that possibility wide open (IMO).
Also note that in the MHRA response the term "approval" was never used while the
term "licensing" was always employed.